What are the diagnostic criteria for Parkinson’s disease

  Step 1: Diagnosing Parkinson’s syndrome
  Decrease in movement: Random movements are slow at the onset, with a gradual decrease in the speed and amplitude of movement for repetitive movements, along with at least one of the following symptoms.
  A. muscle tonicity
  B. resting tremor (4-6 Hz)
  C. Upright instability (caused by non-primary visual, vestibular, cerebellar and proprioceptive dysfunction)
  Step 2: Parkinson’s disease exclusion criteria
  History of recurrent stroke with stepwise progression of Parkinson’s symptoms
  History of recurrent brain injury
  definite history of encephalitis
  moving eye crisis
  being treated with neuroleptics at the time of symptom onset
  1 or more relatives with the disease
  Persistent remission of disease
  Strictly unilateral involvement three years after onset
  supranuclear gaze palsy
  cerebellar signs
  Severe autonomic involvement at an early stage
  Severe early dementia with memory, speech and behavior deficits
  Positive pyramidal fasciculus sign (Babinski’s sign +)
  Intracranial tumor or traffic hydrocephalus on CT scan
  Ineffective treatment with high doses of levodopa (except for absorption disorders)
  MPTP exposure history an opioid analgesic derivative
  Step 3: Supporting diagnostic criteria for Parkinson’s disease. The diagnosis of Parkinson’s disease is confirmed by having three or more
  Unilateral onset
  Presence of resting tremor
  Progressive disease progression
  Persistent asymmetry of symptoms, with the first side being more severe
  Very good response to treatment with levodopa (70-100%)
  Severe allodynia due to levodopa application
  Treatment effect of levodopa lasts for more than 5 years (including 5 years)
  Clinical disease duration of more than 10 years (including 10 years)
  Patients who meet the diagnostic criteria for Parkinson’s syndrome in step 1, but do not have any of the criteria in step 2, and meet three or more of the criteria in step 3, are clinically diagnosed with Parkinson’s disease.